Position in MLYS
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$42,949,920
-$175,111 QoQ
Shares Held
1,591,917
0.0% QoQ
Ownership
1.80%
of shares outstanding
% of Portfolio
20.80%
of 13F equity value
Holder Rank
#16
of 226 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MLYS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ANDERA PARTNERS holds $136,175,985 across 6 Biotechnology names. MLYS ranks #1 (31.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MLYS |
Mineralys Therapeutics, Inc.
This page
|
1,591,917 | $42,949,920 | |
| 2 | AVLN |
Avalyn Pharma Inc.
|
929,824 | $30,609,806 | |
| 3 | AGMB |
Agomab Therapeutics NV
|
1,538,702 | $19,972,351 | |
| 4 | EVMN |
Evommune, Inc.
|
1,391,990 | $18,499,547 | |
| 5 | IVA |
Inventiva S.A.
|
3,633,181 | $13,733,424 | |
| 6 | ABVX |
Abivax S.A.
|
78,125 | $10,410,937 |
All Filings in MLYS
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $42,949,920 | 1,591,917 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $43,125,031 | 1,591,917 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $57,770,667 | 1,591,917 | Shares | Sole | 2026-02-17 | |
| 2025-06-30 | $37,423,655 | 2,765,976 | Shares | Sole | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||